tirzepatide laboratory | Research Peptide Tirzepatide 10mg — GLP-1/GIP Dual-Agonist
Description
A man who started at 280 pounds might be approaching 230 by week 24
Label every vial Both compounds use U-100 insulin syringes
It has been proven to help people lose around 22.5%* of their initial body weight by week 72 of treatment, at a maximum dose of 15 mg
Patients typically combine Zepbound with lifestyle changes, such as more physical activity and a healthy diet, for better weight loss results
